Compounds > 3,4-dihydroxyphenylacetic acid

3,4-dihydroxyphenylacetic acid and resveratrol

3,4-dihydroxyphenylacetic acid has been researched along with resveratrol in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (66.67)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J1
Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J1
Büyükuysal, RL; Gürsoy, M1
Blanchet, J; Bronchti, G; Bureau, G; DiPaolo, T; Longpré, F; Martinoli, MG; Morissette, M1
Cavanaugh, JE; Parmar, MS; Rose, KM1
Alka, K; Dolly, JO; Henehan, GT; Ryan, BJ1

Other Studies

6 other study(ies) available for 3,4-dihydroxyphenylacetic acid and resveratrol

ArticleYear
Chemical genetics reveals a complex functional ground state of neural stem cells.
    Nature chemical biology, 2007, Volume: 3, Issue:5

    Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells

2007
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
    Nature chemical biology, 2009, Volume: 5, Issue:10

    Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection

2009
Resveratrol protects rat striatal slices against anoxia-induced dopamine release.
    Neurochemical research, 2008, Volume: 33, Issue:9

    Topics: 3,4-Dihydroxyphenylacetic Acid; Adenosine Triphosphate; Animals; Antioxidants; Corpus Striatum; Dopamine; Dopamine Uptake Inhibitors; Enzyme Inhibitors; Female; Hypoxia; Male; Nomifensine; Ouabain; Rats; Rats, Wistar; Resveratrol; Stilbenes

2008
Resveratrol, a red wine polyphenol, protects dopaminergic neurons in MPTP-treated mice.
    Progress in neuro-psychopharmacology & biological psychiatry, 2008, Jul-01, Volume: 32, Issue:5

    Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Animals, Newborn; Cell Count; Disease Models, Animal; Docosahexaenoic Acids; Dopamine; Homovanillic Acid; Male; Mice; Mice, Inbred C57BL; MPTP Poisoning; Neurons; Resveratrol; Stilbenes; Substantia Nigra; Tyrosine 3-Monooxygenase

2008
Dietary supplementation with resveratrol protects against striatal dopaminergic deficits produced by in utero LPS exposure.
    Brain research, 2014, Jul-21, Volume: 1573

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dietary Supplements; Disease Models, Animal; Dopamine; Dopamine Plasma Membrane Transport Proteins; Female; Homovanillic Acid; Lipopolysaccharides; Maternal Nutritional Physiological Phenomena; Neurons; Neuroprotective Agents; Pregnancy; Pregnancy Complications, Infectious; Prenatal Exposure Delayed Effects; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Tyrosine 3-Monooxygenase

2014
New inhibitors of the Kvβ2 subunit from mammalian Kv1 potassium channels.
    The international journal of biochemistry & cell biology, 2014, Volume: 55

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Binding, Competitive; Brain; Catechols; Cortisone; Kinetics; NADP; Oxidation-Reduction; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Protein Binding; Rats; Resveratrol; Rutin; Shaker Superfamily of Potassium Channels; Stilbenes; Valproic Acid

2014